Your session is about to expire
← Back to Search
Electrolyte Supplement
Dietary Potassium/Sodium Balance for Cardiovascular Health
N/A
Recruiting
Led By Shannon L Lennon, PhD
Research Sponsored by University of Delaware
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up on day 7 and 10 of diet
Awards & highlights
Study Summary
This trial will investigate the role of dietary potassium on the vasculature in the presence of a high sodium diet in salt-resistant adults.
Who is the study for?
This trial is for healthy adults with normal blood pressure and ECG who aren't on medication, not endurance athletes, non-smokers, not pregnant or obese (BMI under 30), without diabetes, kidney disease, special diets (like gluten-free or vegan), hypertension or heart disease history.Check my eligibility
What is being tested?
The study tests the effects of different diets on blood vessels: one diet has moderate potassium/low sodium; another has moderate potassium/high sodium; and a third has high potassium/high sodium. It aims to see how dietary potassium affects people's vasculature when they consume a lot of salt.See study design
What are the potential side effects?
Since this trial involves dietary changes rather than medications, side effects may include changes in digestion or energy levels due to alterations in nutrient intake. Specific side effects will depend on individual reactions to diet adjustments.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ on day 7 and 10 of diet
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~on day 7 and 10 of diet
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Conduit artery endothelial-dependent dilation
Microvascular function
Secondary outcome measures
Ambulatory BP monitoring
Trial Design
3Treatment groups
Experimental Treatment
Group I: Moderate Potassium/Low SodiumExperimental Treatment1 Intervention
Subjects will be provided with a diet that is moderate in potassium and low in sodium.
Group II: Moderate Potassium/High SodiumExperimental Treatment1 Intervention
Subjects will be provided with a diet that is moderate in potassium and high in sodium.
Group III: High Potassium/High SodiumExperimental Treatment1 Intervention
Subjects will be provided with a diet that is high in both potassium and sodium.
Find a Location
Who is running the clinical trial?
University of DelawareLead Sponsor
154 Previous Clinical Trials
25,121 Total Patients Enrolled
7 Trials studying Cardiovascular Risk
308 Patients Enrolled for Cardiovascular Risk
Shannon L Lennon, PhDPrincipal InvestigatorUniversity of Delaware
2 Previous Clinical Trials
62 Total Patients Enrolled
2 Trials studying Cardiovascular Risk
62 Patients Enrolled for Cardiovascular Risk
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have kidney disease.My BMI is 30 or higher.You are currently pregnant.I am taking medication for my condition.You follow a specific diet that excludes gluten or animal products.You use tobacco products.You have experienced significant weight gain or loss in the last 6 months.I have high blood pressure.My blood pressure is within the normal range.I have a history of heart disease.You are in good health with no underlying medical conditions.Athletes who have trained extensively for endurance events.I have diabetes.
Research Study Groups:
This trial has the following groups:- Group 1: Moderate Potassium/Low Sodium
- Group 2: High Potassium/High Sodium
- Group 3: Moderate Potassium/High Sodium
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Could elderly individuals be included in this research endeavor?
"This research is open to adults aged 18 and under 45."
Answered by AI
Is this research still recruiting participants?
"Affirmative, according to clinicaltrials.gov this trial is currently seeking out participants. Initiated on January 16th 2020 and most recently updated November 12th 2021, the study requires 90 individuals from a single site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger